StocksA › AZZ

AZZ Inc. (AZZ) — Earnings Call X-Ray

Our AI read all 39 of AZZ's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2026 · sign up to see
Previous Call Grade
B+
Q4 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
39
2016–2025
Avg Candor
7.3/9
evasion 2.2/9
High CandorSkeptic ReassuredClean CallVolume Step-UpUnderused Fixed CostsRaising PricesMargins ExpandingResults Worse Than Direction

Call-by-call analysis

🔒 Q1 2026 earnings call 2025-07-10 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2026 call grade is ready
The full 37-point AI read of AZZ's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

B+ Q4 2025 earnings call 2025-04-22 move ±12.1%

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: expandingBacklog: stablePricing: raisingCapex: decreasing 7 analysts · 19 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q3 2025 earnings call 2025-01-08 move ±8.5%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: mixedMargins: expandingPricing: raisingCapex: flat 7 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 7/9
Specificity 8/9
Evasion 1/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

A Q2 2025 earnings call 2024-10-10 move ±8.2%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: mixedMargins: expandingPricing: stableCapex: increasing 6 analysts · 16 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 8/9
Specificity 8/9
Evasion 1/9
Confidence 8/9
Uncertainty 3/9
Promotion 4/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

A Q1 2025 earnings call 2024-07-11 move ±7.6%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: maintainedDemand: acceleratingMargins: expandingPricing: stableCapex: flat 6 analysts · 12 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 7/9
Specificity 8/9
Evasion 1/9
Confidence 8/9
Uncertainty 4/9
Promotion 4/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

A Q4 2024 earnings call 2024-04-22 move ±14.8%

Management raised guidance against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingPricing: raisingCapex: increasing 4 analysts · 12 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 7/9
Specificity 8/9
Evasion 1/9
Confidence 8/9
Uncertainty 2/9
Promotion 5/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

A Q3 2024 earnings call 2024-01-10 move ±7.7%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: mixedMargins: expandingBacklog: stablePricing: under pressureCapex: increasing 4 analysts · 11 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 4/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q2 2024 earnings call 2023-10-11 move ±7.6%

Management held guidance steady against mixed demand signals. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: stableBacklog: growingPricing: raisingCapex: increasing 6 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2024 2023-07-10 B maintainedmixedstable 7/9 1/9
Q4 2023 2023-04-26 C+ maintainedstablecontracting 7/9 2/9
Q3 2023 2023-01-10 B raisedstablecontracting 7/9 2/9
Q2 2023 2022-10-11 F withdrawnstablecontracting 7/9 3/9
Q1 2023 2022-07-11 C withdrawnstableexpanding 7/9 2/9
Q4 2022 2022-04-22 D withdrawnacceleratingexpanding 6/9 3/9
Q3 2022 2022-01-10 C+ maintainedmixedexpanding 7/9 4/9
Q2 2022 2021-10-12 B raisedacceleratingexpanding 7/9 3/9
Q1 2022 2021-07-09 B+ raisedacceleratingexpanding 7/9 4/9
Q4 2021 2021-04-23 B maintainedacceleratingexpanding 8/9 2/9
Q3 2021 2021-01-11 C withdrawnmixedexpanding 7/9 2/9
Q2 2021 2020-10-13 D withdrawnmixedstable 7/9 3/9
Q2 2021 2020-10-13 D withdrawnmixedstable 7/9 3/9
Q1 2021 2020-07-09 D withdrawnmixedcontracting 8/9 2/9
Q4 2020 2020-04-29 C withdrawnmixedexpanding 8/9 2/9
Q3 2020 2020-01-09 A maintainedmixedexpanding 7/9 1/9
Q2 2020 2019-12-05 A raisedmixedexpanding 7/9 2/9
Q1 2020 2019-07-08 C+ maintainedmixedexpanding 7/9 2/9
Q4 2019 2019-05-20 C+ maintainedmixedexpanding 7/9 2/9
Q3 2019 2019-01-08 B maintainedstablecontracting 8/9 2/9
Q2 2019 2018-10-09 B raisedacceleratingcontracting 7/9 2/9
Q1 2019 2018-07-03 B maintainedacceleratingcontracting 7/9 2/9
Q4 2018 2018-05-15 C nonemixedcontracting 8/9 2/9
Q2 2018 2017-10-03 D loweredmixedcontracting 8/9 2/9
Q1 2018 2017-07-06 C+ maintainedmixedcontracting 8/9 2/9
Q4 2017 2017-04-20 F loweredmixedcontracting 8/9 2/9
Q3 2017 2017-01-06 F withdrawnslowingcontracting 7/9 4/9
Q2 2017 2016-10-05 D withdrawnmixedcontracting 7/9 3/9
Q1 2017 2016-07-05 C+ maintainedmixedexpanding 7/9 2/9
Q4 2016 2016-04-21 C+ maintainedmixedexpanding 7/9 2/9
Q3 2016 2016-01-08 D maintainedmixedcontracting 7/9 5/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of AZZ's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

B Q3 2023 earnings call 2023-01-10

1 more research questions answered NO

B Q2 2022 earnings call 2021-10-12

1 more research questions answered NO

B Q2 2019 earnings call 2018-10-09

1 more research questions answered NO

F Q4 2017 earnings call 2017-04-20

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAN · The Aaron's Company, IncAAWW · Atlas Air Worldwide HoldABAX · ABAXISABCB · Ameris BancorpABM · ABM Industries IncorporaACBI · Atlantic Capital Bancsha

AZYO   All “A” companies    B

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.